Dr. Rukowski's scientific activities are focused on sarcoma research (multimodal treatment and prognostic factors), GIST (molecular aspects of treatment of advance disease and mechanisms of resistance to targeted therapy) and melanoma (sentinel node biopsy tissues, adjuvant therapy, detection of submicroscopic disease and circulating molecular prognostic makers). He has participated in several investigator driven trials in sarcoma and melanoma and is a member of the steering committee of the CAMN107A2201 GIST trial. He is coordinator of the Polish Clinical GIST Registry and is a reviewer for the European Journal of Surgical Oncology, the World Journal of Surgical Oncology and The Lancet journal. He is a member of several Polish (board member of Polish Society Surgical Oncology) and international scientific societies, an active member of EORTC Soft Tissue and Bone Sarcoma Group, EORTC Melanoma Group, and the Global Melanoma Task Force. Dr. Rutkowski has authored or co-authored over 80 scientific papers in Polish and international journals, and is co-author of national and international recommendations in sarcoma and melanoma. He is working very closely in national patients' advocacy groups for GIST and sarcoma.